205 related articles for article (PubMed ID: 16520133)
1. Assessment of quality of life in patients with chronic heart failure secondary to Chagas' cardiomyopathy.
Dourado KC; Bestetti RB; Cordeiro JA; Theodoropoulos TA
Int J Cardiol; 2006 Apr; 108(3):412-3. PubMed ID: 16520133
[TBL] [Abstract][Full Text] [Related]
2. QT interval dispersion in patients with chronic heart failure secondary to Chagas' cardiomyopathy: correlation with clinical variables of prognostic significance.
Corbucci HA; Haber DM; Bestetti RB; Cordeiro JA; Fioroni ML
Cardiovasc Pathol; 2006; 15(1):18-23. PubMed ID: 16414452
[TBL] [Abstract][Full Text] [Related]
3. Heart failure survival score in patients with Chagas disease: correlation with functional variables.
Ritt LE; Carvalho AC; Feitosa GS; Pinho-Filho JA; Macedo CR; Vilas-Boas F; Andrade MV; Feitosa-Filho GS; Almeida AJ; Barojas M; Lopes RD
Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):538-43. PubMed ID: 22513344
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.
Freitas HF; Chizzola PR; Paes AT; Lima AC; Mansur AJ
Int J Cardiol; 2005 Jul; 102(2):239-47. PubMed ID: 15982491
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of anemia in patients with chronic systolic heart failure secondary to Chagas' cardiomyopathy.
Miguel CE; Bortoluzzi TB; Otaviano AP; Cardinalli-Neto A; Rocha BF; Ferrari SJ; Bestetti RB
Acta Trop; 2011 Dec; 120(3):219-23. PubMed ID: 21906579
[TBL] [Abstract][Full Text] [Related]
6. Assessment of QTc interval dispersion in patients with chronic heart failure secondary to Chagas-Hypertensive cardiomyopathy.
Pinheiro MB; Bestetti RB; Cordeiro JA
Int J Cardiol; 2007 Sep; 121(1):93-4. PubMed ID: 17126936
[TBL] [Abstract][Full Text] [Related]
7. [Predicting heart failure and mortality in chronic Chagas' heart disease. A novel disorder in Spain].
Acquatella H
Rev Esp Cardiol; 2008 Feb; 61(2):105-7. PubMed ID: 18364176
[No Abstract] [Full Text] [Related]
8. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy.
Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM
Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706
[TBL] [Abstract][Full Text] [Related]
9. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC
Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318
[TBL] [Abstract][Full Text] [Related]
10. [Normal maximal functional capacity in patients with congestive heart failure due to Chagas' cardiomyopathy].
Mady C; Cardosa RH; Ianni BM; Arteaga E; Koide NS; Silva PR; da Luz PL; Bellotti G; Pileggi F
Arq Bras Cardiol; 1996 Jul; 67(1):1-4. PubMed ID: 9035458
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
[TBL] [Abstract][Full Text] [Related]
12. Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure.
Bestetti RB; Otaviano AP; Cardinalli-Neto A; da Rocha BF; Theodoropoulos TA; Cordeiro JA
Int J Cardiol; 2011 Sep; 151(2):205-8. PubMed ID: 20591516
[TBL] [Abstract][Full Text] [Related]
13. [Use of the Minnesota Living With Heart Failure Quality of Life Questionnaire in Spain].
Parajón T; Lupón J; González B; Urrutia A; Altimir S; Coll R; Prats M; Valle V
Rev Esp Cardiol; 2004 Feb; 57(2):155-60. PubMed ID: 14967111
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the six-minute walk test in patients with chronic heart failure associated with Chagas' disease and systemic arterial hypertension.
Dourado KC; Bestetti RB; Cardinalli-Neto A; Cordeiro JA
Rev Soc Bras Med Trop; 2010; 43(4):405-8. PubMed ID: 20802940
[TBL] [Abstract][Full Text] [Related]
15. Respiratory muscle strength, the six-minute walk test and quality of life in Chagas cardiomyopathy.
Vieira FC; de Melo Marinho PÉ; Brandão DC; Barbosae e Silva O
Physiother Res Int; 2014 Mar; 19(1):8-15. PubMed ID: 23703777
[TBL] [Abstract][Full Text] [Related]
16. Is Chagas cardiomyopathy an independent risk factor for patients with heart failure?
Braga JC; Reis F; Aras R; Dantas N; Bitencourt A; Neves FS; Latado AL
Int J Cardiol; 2008 May; 126(2):276-8. PubMed ID: 17467084
[TBL] [Abstract][Full Text] [Related]
17. [Predictors of heart failure in chronic chagasic cardiomyopathy with asymptomatic left ventricular dysfunction].
Petti MA; Viotti R; Armenti A; Bertocchi G; Lococo B; Alvarez MG; Vigliano C
Rev Esp Cardiol; 2008 Feb; 61(2):116-22. PubMed ID: 18364179
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of cholelithiasis in necropsies of patients with chronic Chagas' disease in the mining triangle--correlation with megaesophagus, megacolon and cardiac insufficiency].
Rocha A; Almeida Hde O; Teixeira Vde P; da Silva AM
Arq Gastroenterol; 1985; 22(1):3-6. PubMed ID: 3936459
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy.
Bestetti RB; Muccillo G
Int J Cardiol; 1997 Jul; 60(2):187-93. PubMed ID: 9226290
[TBL] [Abstract][Full Text] [Related]
20. Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease.
Bestetti RB; Coutinho-Netto J; Staibano L; Pinto LZ; Muccillo G; Oliveira JS
Cardiology; 1995; 86(3):202-6. PubMed ID: 7614491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
